Synthetic dopamine agonists

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.3, Iss.4, 2002-04, pp. : 363-364

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

. . . and ergot-derived dopamine agonists . . .

Reactions Weekly, Vol. 1, Iss. 1209, 2008-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Prevention of OHSS – dopamine agonists

By Busso Cristiano E Garcia-Velasco Juan Gomez Raúl Álvarez Claudio Simón Carlos Pellicer Antonio

Reproductive BioMedicine Online, Vol. 19, Iss. 1, 2009-07 ,pp. : 43-51

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Dopamine D3 agonists

By Emilien Gérard Durlach Cécile Aveaux Dominique Maloteaux Jean-Marie

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 11, 2001-11 ,pp. : 1713-1728

Informa Healthcare

Access to resources Recommend Favorite

Dopamine receptor agonists for treating prolactinomas

By Colao Annamaria Somma Carolina di Lombardi Gaetano Pivonello Rosario Sarno Antonella di

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 6, 2002-06 ,pp. : 787-800

Informa Healthcare

Access to resources Recommend Favorite

Dopamine agonists in Parkinson’s disease

By Tintner Ron Jankovic Joseph

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 11, 2003-11 ,pp. : 1803-1820

Informa Healthcare

Access to resources Recommend Favorite